Literature DB >> 15987351

SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.

Jun Akiba1, Takeji Umemura, Harvey J Alter, Masamichi Kojiro, Edward Tabor.   

Abstract

SEN virus (SEN-V) is a blood-borne, single-stranded, nonenveloped DNA virus. Although its prevalence varies by geographic region, it has been detected in as many as 30 percent of postoperative transfusion recipients, compared to 3 percent of postoperative patients who did not receive transfusions. A significant association has been observed between transfusion volume and the occurrence of SEN-V infection. Transmission by transfusion also has been confirmed by the detection of greater than 99 percent homology between SEN-V in donor and recipient sera. Concurrent infections with SEN-V and hepatitis B virus, hepatitis C virus, or human immunodeficiency virus type 1 have been documented, and these observations probably reflect the blood-borne transmission of these viruses as well as SEN-V. Although SEN-V was discovered as part of a search for causes of posttransfusion hepatitis, there is no firm evidence so far that SEN-V infection either causes hepatitis or worsens the course of coexistent liver disease. Nevertheless, SEN-V appears to be transmitted by transfusion, and further studies may reveal more about its role in the future.

Entities:  

Mesh:

Year:  2005        PMID: 15987351     DOI: 10.1111/j.1537-2995.2004.00209.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  A comment on blood transfusion practice resulting from the data on the prevalence of SEN virus DNA in donated blood samples.

Authors:  Viroj Wiwanitkit
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

Review 2.  Cryptogenic chronic hepatitis and its changing guise in adults.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

3.  Quantitative assessment of serum NV-F virus DNA concentrations in samples from patients coinfected with hepatitis B or C virus.

Authors:  Chao-Wei Hsu; Ju-Chien Cheng; Chau-Ting Yeh
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Emerging infectious threats to the blood supply: seroepidemiological studies in iran - a review.

Authors:  Gharib Karimi; Ahmad Gharehbaghian; Mohammad Fallah Tafti; Vida Vafaiyan
Journal:  Transfus Med Hemother       Date:  2013-05-17       Impact factor: 3.747

5.  SEN virus infection in Egyptian patients with chronic hepatitis C and patients undergoing hemodialysis.

Authors:  Maisa Omar; Samah Saad El-Din; Nevine Fam; Manal Diab; Mohamed Shemis; Manar Raafat; Moataz Seyam; Moataz Hssan; Afkar Badawy; Maha Akl; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-12-24

6.  High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran.

Authors:  Abbas Karimi-Rastehkenari; Majid Bouzari
Journal:  Virol J       Date:  2010-01-02       Impact factor: 4.099

Review 7.  The Role of Emerging and Neglected Viruses in the Etiology of Hepatitis.

Authors:  Anna Mrzljak; Irena Tabain; Hrvoje Premac; Maja Bogdanic; Ljubo Barbic; Vladimir Savic; Vladimir Stevanovic; Ana Jelic; Danko Mikulic; Tatjana Vilibic-Cavlek
Journal:  Curr Infect Dis Rep       Date:  2019-11-21       Impact factor: 3.663

Review 8.  Transfusion-transmitted infections.

Authors:  Florian Bihl; Damiano Castelli; Francesco Marincola; Roger Y Dodd; Christian Brander
Journal:  J Transl Med       Date:  2007-06-06       Impact factor: 5.531

9.  Association Between TT Virus Infection and Cirrhosis in Liver Transplant Patients.

Authors:  Mohammad Javad Kazemi; Ramin Yaghobi; Mahdiyar Iravani Saadi; Bita Geramizadeh; Javad Moayedi
Journal:  Hepat Mon       Date:  2015-09-27       Impact factor: 0.660

10.  The Prevalence of SEN Virus and Occult Hepatitis B (OBI) Virus Infection Among Blood Donors in Ahvaz City.

Authors:  Samaneh Abbasi; Manoochehr Makvandi; Gharib Karimi; Niloofar Neisi
Journal:  Jundishapur J Microbiol       Date:  2016-07-03       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.